Neurocrine Biosciences, Inc. (NBIX)
143.18
+2.47
(+1.76%)
USD |
NASDAQ |
Oct 02, 16:00
144.60
+1.42
(+0.99%)
After-Hours: 20:00
Neurocrine Biosciences Total Return Level : 143.18 for Oct. 2, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 02, 2026 | 143.18 |
| October 01, 2026 | 140.71 |
| September 30, 2026 | 141.84 |
| September 29, 2026 | 138.35 |
| September 28, 2026 | 140.44 |
| September 25, 2026 | 138.40 |
| September 24, 2026 | 138.94 |
| September 23, 2026 | 139.49 |
| September 22, 2026 | 142.25 |
| September 21, 2026 | 143.96 |
| September 18, 2026 | 146.23 |
| September 17, 2026 | 151.83 |
| September 16, 2026 | 149.50 |
| September 15, 2026 | 150.02 |
| September 14, 2026 | 157.22 |
| September 11, 2026 | 156.22 |
| September 10, 2026 | 156.57 |
| September 09, 2026 | 155.14 |
| September 08, 2026 | 155.13 |
| September 04, 2026 | 155.64 |
| September 03, 2026 | 158.35 |
| September 02, 2026 | 157.79 |
| September 01, 2026 | 156.76 |
| August 31, 2026 | 154.03 |
| August 28, 2026 | 154.06 |
| Date | Value |
|---|---|
| August 27, 2026 | 155.92 |
| August 26, 2026 | 156.59 |
| August 25, 2026 | 153.37 |
| August 24, 2026 | 153.04 |
| August 21, 2026 | 152.57 |
| August 20, 2026 | 152.93 |
| August 19, 2026 | 155.54 |
| August 18, 2026 | 154.23 |
| August 17, 2026 | 154.49 |
| August 14, 2026 | 152.72 |
| August 13, 2026 | 150.82 |
| August 12, 2026 | 156.49 |
| August 11, 2026 | 161.94 |
| August 10, 2026 | 164.92 |
| August 07, 2026 | 163.41 |
| August 06, 2026 | 159.82 |
| August 05, 2026 | 161.50 |
| August 04, 2026 | 166.06 |
| August 03, 2026 | 166.23 |
| July 31, 2026 | 166.80 |
| July 30, 2026 | 185.50 |
| July 29, 2026 | 180.79 |
| July 28, 2026 | 182.83 |
| July 27, 2026 | 176.41 |
| July 24, 2026 | 175.77 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Amarin Corp. Plc | 12.35 |
| Liquidia Corp. | 28.64 |
| BioCryst Pharmaceuticals, Inc. | 8.17 |
| Halozyme Therapeutics, Inc. | 109.86 |
| Iovance Biotherapeutics, Inc. | 14.22 |